Skip to content

Effect of Fu's Subcutaneous Needling on Postoperative Acute Pain in Patients With Lumbar Spine Surgery.

Effect of Fu's Subcutaneous Needling on Postoperative Acute Pain in Patients With Lumbar Spine Surgery: a Single-blinded Randomized, Control Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05572931
Enrollment
49
Registered
2022-10-10
Start date
2021-03-08
Completion date
2023-06-25
Last updated
2024-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Postoperative

Keywords

Fu's Subcutaneous Needling, postoperative pain

Brief summary

The goal of this clinical trial is to evaluate Fu's Subcutaneous Needling (FSN) in postoperative pain in patients with Lumbar Spine Surgery (LSS). The main questions it aims to answer are: * Is FSN effective for postoperative pain? * Dose FSN decrease the tissue hardness after LSS? * Dose FSN have the effect of anti-inflammatory after LSS? Participants will receive routine analgesic and FSN after LSS. Researchers will compare Sham group to see if FSN being effective for postoperative pain.

Interventions

Insertion points are both sides of 1) inferior edge of the scapula; 2)the midpoint of inferior edge of the posterior superior iliac spine and the ischial tuberosity. FSN (Trocar Acupuncture Needle, Nanjing FSN Medical Co. , Ltd, China.) ) is a solid needle with plastic cannula tube on the outside. Add on swaying movement (SM) and reperfusion approach (RA) after the needle inserting into the subcutaneous layer. The SM is a horizontal fan sway movement with the base of the needle for the fulcrum, The SM speed is 200 times in 2 minutes. Apply RA when performing SM. RA movement is hip extension in prone position with resistance by physician's hand for 10 seconds. And then rest for 10 seconds. Repeat 3 cycles. The same RA is performed over the other three insertion point.

DEVICEfine acupuncture needle

(36G, 0.5 inch, Wujiang city cloud & dragon medical device Co.,Ltd.) Only inserted to skin, not into the subcutaneous layer. No SM and RA.

Sponsors

China Medical University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* Pain and neurological symptoms are caused by degeneration of the spine (L1-S1) and require surgery. * One hour after lumbar spine surgery (evaluated after returning to the ward from the recovery room) Visual analogue scale (VAS) score ≥ 5 points * After being explained, join the trial voluntarily and sign the subject's consent form.

Exclusion criteria

* Pain caused by acute trauma. * major diseases such as heart and lung failure, cancer, chronic kidney disease. * psychiatric disorder. * History of substance abuse. * A history of spinal surgery. * Refused sign the consent form.

Design outcomes

Primary

MeasureTime frameDescription
Change of Taiwanese version of the Brief Pain Inventory (BPI-T) Short FormChange from Baseline BPI-T at the 1st、24th、48th、72nd hour after surgery.BPI-T Short Form
The total dosage of analgesic drugThe amount of intravenous opioid drug (Pethidine 50mg/vail) within 72 hours after surgery.opioid drug (Pethidine 50mg/vail)

Secondary

MeasureTime frameDescription
Change of Blood serum C-reactive protein (CRP)Change from Baseline CRP at the 24th, 72nd hour, 1st month after surgery.Biochemistry
Change of Blood serum IL-1ẞ、IL-2、IL-6Change from Baseline IL-1ẞ、IL-2、IL-6 at the 24th, 72nd hour, 1st month after surgery.Biochemistry
Change of Blood serum TNF-αChange from Baseline TNF-α at the 24th, 72nd hour, 1st month after surgery.Biochemistry
Change of Tissue hardness (TH)Change from Baseline TH at the 1st、24th、48th、72nd hour after surgery.The points for measuring TH were the inferior border of the scapula, two centimeters horizontal from the midline of the L3 level, and the gluteus maximus.

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026